A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Clinical trial NCT07438496 · RECRUITING
Trial details
- NCT number
- NCT07438496
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2028-12-06
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.